Oxford University Press, The Journal of Infectious Diseases, 11(207), p. 1694-1702, 2013
Full text: Download
Background. The long-term impact of allogeneic hematopoietic stem cell transplantation (HSCT) on human immunodeficiency virus type 1 (HIV-1) reservoirs in patients receiving combination antiretroviral therapy (cART) is largely unknown.